Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Bluebird bio, Inc.    BLUE

BLUEBIRD BIO, INC.

(BLUE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
All news about BLUEBIRD BIO, INC.
08:06aBLUEBIRD BIO : Announces Live Webcast to Review Clinical Data Presented at the A..
BU
11/19BLUEBIRD BIO : Corporate Presentation - November 2020
PU
11/10SHAREHOLDER ALERT : Pomerantz Law Firm Investigates Claims On Behalf of Investor..
PR
11/10BLUEBIRD BIO : Announces November Investor Events
BU
11/05BLUEBIRD BIO : to Present Data from Gene and Cell Therapy Programs During the 62..
BU
11/04BLUEBIRD : 3Q Earnings Snapshot
AQ
11/04BLUEBIRD BIO : Management's Discussion and Analysis of Financial Condition and R..
AQ
11/04BLUEBIRD BIO : Reports Third Quarter 2020 Financial Results and Highlights Opera..
BU
11/04BLUEBIRD BIO, INC. : Results of Operations and Financial Condition, Financial St..
AQ
10/02BLUEBIRD BIO, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
10/02BLUEBIRD BIO : Announces European Medicines Agency's Acceptance of Marketing Aut..
BU
10/01BLUEBIRD BIO, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
09/28BLUEBIRD BIO : Corporate Presentation - September 2020
PU
09/28BLUEBIRD BIO : to Present at Jefferies Cell Therapy Virtual Summit
BU
09/23BLUEBIRD BIO, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
09/23BLUEBIRD BIO : LentiGlobin™ for Sickle Cell Disease Gene Therapy (bb1111) ..
BU
09/22BLUEBIRD BIO, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
09/22Bristol Myers, Bluebird Get FDA Priority Review for Ide-cel
DJ
09/02BLUEBIRD BIO : Announces September Investor Events
BU
08/31BLUEBIRD BIO, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
08/29BLUEBIRD BIO : Presents New Results from Clinical Development Program of elivald..
BU
08/18BLUEBIRD BIO, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
08/18BLUEBIRD BIO : Corporate Presentation Q3 2020
PU
08/17BLUEBIRD BIO : to Present New Data from Clinical Studies of elivaldogene autotem..
BU
08/11BLUEBIRD BIO, INC. : Change in Directors or Principal Officers, Regulation FD Di..
AQ
08/11BLUEBIRD BIO : Appoints Denice Torres to Board of Directors
BU
08/05BLUEBIRD : 2Q Earnings Snapshot
AQ
08/05BLUEBIRD BIO : Management's Discussion and Analysis of Financial Condition and R..
AQ
08/05BLUEBIRD BIO, INC. : Results of Operations and Financial Condition, Financial St..
AQ
08/05BLUEBIRD BIO : Reports Second Quarter 2020 Financial Results and Recent Operatio..
BU
07/31BLUEBIRD BIO : Announces August Investor Event
BU
07/30BRISTOL MYERS SQUIBB : and bluebird bio Announce Submission of Biologics License..
AQ
07/29BLUEBIRD BIO, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
06/23BLUEBIRD BIO, INC. : Submission of Matters to a Vote of Security Holders (form 8..
AQ
06/12BLUEBIRD BIO, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
06/12BLUEBIRD BIO : New Data Show Near Elimination of Sickle Cell Disease-Related Vas..
BU
06/12BLUEBIRD BIO : Majority of Evaluable Patients Across Genotypes Achieve Transfusi..
BU
06/03BLUEBIRD BIO : Announces That Its 2020 Annual Meeting of Stockholders Will Be He..
BU
05/28BLUEBIRD BIO : Announces Live Webcast of EHA Data Review and June Investor Event..
BU
05/22Bristol Myers Says EMA Validates Applications for Idecabtagene Vicleucel, CC-..
DJ
05/19BLUEBIRD BIO, INC. : Entry into a Material Definitive Agreement, Other Events, F..
AQ
05/18BLUEBIRD BIO : Announces Pricing of Public Offering of Common Stock
BU
05/18BLUEBIRD BIO : Announces Proposed Public Offering of Common Stock
BU
05/14BLUEBIRD BIO : to Present Data from Its Gene and Cell Therapy Programs During th..
BU
05/14BRISTOL MYERS SQUIBB : and bluebird bio Provide Regulatory Update on Idecabtagen..
AQ
05/13BLUEBIRD BIO, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
05/11BLUEBIRD BIO : First Quarter 2020 Earnings Presentation
PU
05/11BLUEBIRD BIO : Bristol Myers to pay bluebird $200 million for future royalties o..
RE
05/11BLUEBIRD BIO : Management's Discussion and Analysis of Financial Condition and R..
AQ
05/11BLUEBIRD BIO, INC. : Results of Operations and Financial Condition, Other Events..
AQ
05/11BLUEBIRD BIO : Announces Amended BCMA CAR-T Collaboration Agreement
BU
05/11BLUEBIRD : 1Q Earnings Snapshot
AQ
05/11BLUEBIRD BIO : Provides Operational and Business Update and Reports First Quarte..
BU
05/08BLUEBIRD BIO : to Present Updated Results From Pivotal Phase 2 KarMMa Study of I..
BU
04/29BLUEBIRD BIO : Announces First Quarter 2020 Earnings Conference Call and May Inv..
BU
04/01BRISTOL MYERS SQUIBB : and bluebird bio Announce Submission of Biologics License..
AQ
03/31BLUEBIRD BIO, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
03/26BLUEBIRD BIO, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
03/26BLUEBIRD BIO : Provides Assessment of Impact of COVID-19, Update on Business Ope..
BU
03/12BLUEBIRD BIO, INC. : Entry into a Material Definitive Agreement, Financial State..
AQ
02/26BLUEBIRD BIO, INC. : annual earnings release
02/18BLUEBIRD BIO : Securities offered to employees pursuant to employee benefit plan..
PU
02/18BLUEBIRD : 4Q Earnings Snapshot
AQ
02/18BLUEBIRD BIO : Management's Discussion and Analysis of Financial Condition and R..
AQ
02/18BLUEBIRD BIO, INC. : Results of Operations and Financial Condition, Financial St..
AQ
02/18BLUEBIRD BIO : Reports Fourth Quarter and Full Year 2019 Financial Results and H..
BU
02/05BLUEBIRD BIO : Announces Upcoming Investor Events
BU
01/21BLUEBIRD BIO, INC. : Entry into a Material Definitive Agreement, Financial State..
AQ
01/13BLUEBIRD BIO, INC. : Results of Operations and Financial Condition, Regulation F..
AQ
01/13BLUEBIRD BIO : Announces Launch in Germany of ZYNTEGLO™ (autologous CD34+ ..
BU
2019BLUEBIRD BIO : Announces Investor Events in January
BU
2019BLUEBIRD BIO : and Bristol-Myers Squibb Present Updated Data from Ongoing Phase ..
AQ
2019BLUEBIRD BIO, INC. : Regulation FD Disclosure, Other Events, Financial Statement..
AQ
2019BLUEBIRD BIO : and Bristol-Myers Squibb Present Updated Data from Ongoing Phase ..
BU
2019BLUEBIRD BIO : Presents New Data Demonstrating Long-Term Transfusion Independenc..
BU
1  2  3  4  5Next